Acquiring Company is considering buying Target Company. Target Company is a small biotechnology firm that develops products licensed to the major pharmaceutical firms. Development costs are expected to generate negative cash flows during the first two years of the forecast period of $(10) million and $(5) million, respectively. Licensing fees are expected to generate positive cash flows during years 3 through 5 of the forecast period of $5 million, $10 million, and $15 million, respectively. Because of the emergence of competitive products, cash flow is expected to grow at a modest 5% annually after the fifth year. The discount rate for the first five years is estimated to be 20% and then to drop to the industry average rate of 10% beyond the fifth year. Also, the present value of the estimated net synergy by combining Acquiring and Target companies is $30 million. Calculate the minimum and maximum purchase prices for Target Company. Show your work.